Content validity of the PedsQL™ 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8-45. (Q38069951)

28 August 2017

Content validity of the PedsQL™ 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8-45. (English)

1 reference

28 August 2017

0 references

James W Varni

1

1 reference

28 August 2017

Bradley H Curtis

2

1 reference

28 August 2017

Linda N Abetz

3

1 reference

28 August 2017

Kathryn E Lasch

4

1 reference

28 August 2017

Elisabeth C Piault

5

1 reference

28 August 2017

Andrea A Zeytoonjian

6

1 reference

28 August 2017

27 December 2012

1 reference

28 August 2017

Quality of Life Research

1 reference

28 August 2017

22

1 reference

28 August 2017

8

1 reference

28 August 2017

2169-2181

1 reference

https://scigraph.springernature.com/pub.10.1007/s11136-012-0339-8

28 August 2017

0 references

cites work

The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Type 1 diabetes: etiology, immunology, and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Living with cystic fibrosis-related diabetes or type 1 diabetes mellitus: a comparative study exploring health-related quality of life and patients' reported experiences of hypoglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

The PedsQL: measurement model for the pediatric quality of life inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Demographic and clinical correlates of diabetes-related quality of life among youth with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Generic and diabetes-specific parent-child behaviors and quality of life among youth with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

PRO development: rigorous qualitative research as the crucial foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Qualitative research and content validity: developing best practices based on science and experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO in

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

The risk factors of ketoacidosis in children with newly diagnosed type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Anti-CD3 monoclonal antibody treatment in newly diagnosed Type 1 diabetes patients: a hypothetical modelling analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

GAD treatment and insulin secretion in recent-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

The reliability of the Health Related Quality Of Life questionnaire PedsQL 3.0 Diabetes Module™ for Swedish children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

How Many Interviews Are Enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-012-0339-8

Quality of life in children with Type 1 diabetes: a comparison of general and diabetes-specific measures and support for a unitary diabetes quality-of-life construct

21 January 2018

1 reference

12 December 2020

Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes

1 reference

12 December 2020

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11136-012-0339-8

Identifiers

DOI

1 reference

28 August 2017

1 reference